Stocks
Adagene ADAG
Health care sectorNasdaq
Company
- Exchange
- Nasdaq
- Sector
- Health care
- Industry
- Pharmaceutical Preparations
- Headquarters
- Jiangsu
- Fiscal year end
- 12/31
No member of Congress reported a trade in Adagene ADAG in the past 90 days. Insiders filed 1 purchase and 0 sales on the open market over the same period, a net purchase of $6,000.
- Next earnings
- No record
- Estimated from the last four quarters
26-week trading
Common questions
- Did Adagene ADAG insiders buy or sell in the past 90 days?
- In the past 90 days insiders filed 1 purchase and 0 sales on the open market. Purchases came to $6,000.